Literature DB >> 9589015

The pathophysiology of lower urinary tract symptoms in the ageing male population.

H Lepor1.   

Abstract

Mesh:

Substances:

Year:  1998        PMID: 9589015     DOI: 10.1046/j.1464-410x.1998.0810s1029.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


× No keyword cloud information.
  7 in total

Review 1.  Induction of apoptosis in the prostate by alpha1-adrenoceptor antagonists: a novel effect of "old" drugs.

Authors:  N Kyprianou; S C Jacobs
Journal:  Curr Urol Rep       Date:  2000-08       Impact factor: 3.092

Review 2.  Botulinum A toxin for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms.

Authors:  Catherine A Thomas; Yao-Chi Chuang; Antonella Giannantoni; Michael B Chancellor
Journal:  Curr Urol Rep       Date:  2006-07       Impact factor: 3.092

3.  Transurethral intraprostatic Botulinum toxin-A injection: a novel treatment for BPH refractory to current medical therapy in poor surgical candidates.

Authors:  Ali Hamidi Madani; Ahmad Enshaei; Abtin Heidarzadeh; Gholamreza Mokhtari; Alireza Farzan; Mani Mohiti Asli; Samaneh Esmaeili
Journal:  World J Urol       Date:  2012-03-13       Impact factor: 4.226

Review 4.  New intraprostatic injectables and prostatic urethral lift for male LUTS.

Authors:  Giuseppe Magistro; Christian G Stief; Christian Gratzke
Journal:  Nat Rev Urol       Date:  2015-07-21       Impact factor: 14.432

5.  Analysis of the treatment of two types of acute urinary retention.

Authors:  Kwangsu Park; Sang Hoon Kim; Sun Gook Ahn; Seung-Ju Lee; U-Syn Ha; Jun Sung Koh; Yong-Seok Lee; Chang Hee Han; Su Yeon Cho; Hyun Woo Kim
Journal:  Korean J Urol       Date:  2012-12-20

Review 6.  Intraprostatic Botulinum Neurotoxin Type A Injection for Benign Prostatic Hyperplasia-A Spotlight in Reality.

Authors:  Yu-Chao Hsu; Hung-Jen Wang; Yao-Chi Chuang
Journal:  Toxins (Basel)       Date:  2016-04-26       Impact factor: 4.546

Review 7.  Can Botulinum Toxin A Still Have a Role in Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Through Inhibition of Chronic Prostatic Inflammation?

Authors:  Bing-Juin Chiang; Hann-Chorng Kuo; Chun-Hou Liao
Journal:  Toxins (Basel)       Date:  2019-09-19       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.